Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-09-17 12:31 pm Purchase | 2021-09-13 | 13G | aTyr Pharma, Inc. ATYR | TANG CAPITAL PARTNERS LP | 1,063,453 6.300% | 1,063,453 (New Position) | Filing History |
| 2021-06-21 09:00 am Unchanged | 2021-06-21 | 13D | Aptevo Therapeutics Inc. APVO | TANG CAPITAL PARTNERS LP | 3 39.600% | 0 (Unchanged) | Filing History |
| 2021-06-03 08:30 am Purchase | 2021-05-27 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH | TANG CAPITAL PARTNERS LP | 1,350,180 9.990% | 1,350,180 (New Position) | Filing History |
| 2021-05-27 06:03 am Purchase | 2021-05-26 | 13D | La Jolla Pharmaceutical Company LJPC | TANG CAPITAL PARTNERS LP | 10,126,204 36.800% | 410,714 (+4.23%) | Filing History |
| 2021-02-16 4:15 pm Sale | 2020-12-31 | 13G | Heron Therapeutics, Inc. HRTX | TANG CAPITAL PARTNERS LP | 7,639,100 7.800% | -2,110,244 (-21.64%) | Filing History |
| 2021-02-16 4:15 pm Sale | 2020-12-31 | 13G | Evolus, Inc. EOLS | TANG CAPITAL PARTNERS LP | 0 0.000% | -2,635,000 (Position Closed) | Filing History |
| 2021-02-16 4:15 pm Sale | 2020-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | TANG CAPITAL PARTNERS LP | 200,000 1.200% | -1,100,000 (-84.62%) | Filing History |
| 2021-02-16 4:15 pm Purchase | 2020-12-31 | 13G | AnaptysBio, Inc. ANAB | TANG CAPITAL PARTNERS LP | 2,628,678 9.600% | 784,864 (+42.57%) | Filing History |
| 2021-02-09 08:30 am Unchanged | 2021-02-09 | 13D | Aptevo Therapeutics Inc. APVO | TANG CAPITAL PARTNERS LP | 3 40.200% | 0 (Unchanged) | Filing History |